Effects of inducers and inhibitors on the microsomal metabolism of styrene to styrene oxide in mice

Journal of Toxicology and Environmental Health

Volumn 51, Issue 5, 1997, Pages 477-488

  Carlson, Gary P ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA NAPHTHOFLAVONE; CYTOCHROME P450; DIETHYLDITHIOCARBAMIC ACID; PHENOBARBITAL; PROADIFEN; PYRIDINE; STYRENE; STYRENE OXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL INTERACTION; CONTROLLED STUDY; ENANTIOMER; ENZYME INDUCTION; ENZYME INHIBITION; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER MICROSOME METABOLISM; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TOXICITY TESTING; XENOBIOTIC METABOLISM;

ANIMALS; BETA-NAPHTHOFLAVONE; CARCINOGENS; CYTOCHROME P-450 ENZYME SYSTEM; DITIOCARB; ENZYME INDUCTION; ENZYME INHIBITORS; EPOXY COMPOUNDS; INJECTIONS, INTRAPERITONEAL; LUNG; MALE; MICE; MICROSOMES; MICROSOMES, LIVER; PHENOBARBITAL; PYRIDINES; SPECIES SPECIFICITY; STYRENE; STYRENES;

ANIMALIA;

EID: 0030849186     PISSN: 00984108     EISSN: None     Source Type: Journal    
DOI: 10.1080/00984109708984038     Document Type: Article

References (24)

1. Bond, J. A. 1989. Review of the toxicology of styrene. Crit. Rev. Toxicol. 19:227-249.
2. Carlson, G. P. 1997. Comparison of mouse strains for susceptibility to styrene-induced hepatotoxic-ity and pneumotoxicity. J. Toxicol. Environ. Health 51:177-187.
3. Carlson, G. P. and Day, B. J. 1992. Induction by pyridine of cytochrome P450IIE1 and xenobiotic metabolism in rat lung and liver. Pharmacology 44:117-123.
4. Chang, A., Buckpitt, A., Plopper, C. and Alworth, W. 1996. Suicide inhibition of CYP2F2, the enzyme responsible for naphthalene (NA) metabolism to a Clara cell toxicant. Toxicologist 30:72.
5. Forkert, P. G., Vessey, M. L., Elce, S., Park, S. S., Gelboin, H. V. and Cole, S. P. C. 1986. Localization of phenobarbital- and 3-methylcholanthrene-inducible cytochromes P-450 in mouse lung with monoclonal antibodies. Res. Commun. Chem. Pathol. Pharmacol. 53:147-157.
6. Foureman, G. L., Harris, C., Guengerich, F. P. and Bend, J. R. 1989. Stereochemistry of styrene oxidation in microsomes and in purified cytochrome P-450. enzymes from rat liver. J. Pharmacol. Exp. Ther. 248:492-497.
7. Gadberry, M. G., DeNicola, D. B. and Carlson, G. P. 1996. Pneumotoxicity and hepatotoxicity of styrene and styrene oxide. J. Toxicol. Environ. Health 48:273-294.
8. Iba, M. M., Ghosal, A., Thomas, P. E., Bennett, S. and Storch, A. 1993. Tissue microsomal P450 levels in rats exposed to acetone and pyridine. Toxicologist 13:345.
9. Kaul, K. L. and Novak, R. F. 1987. Inhibition and induction of rabbit liver microsomal cytochrome P-450 by pyridine. J. Pharmacol. Exp. Ther. 243:384-390.
10. Kim, S. G., Philpot, R. M. and Novak, R. F. 1991. Pyridine effects on P450IIE1, I IB and IVB expression in rabbit liver: Characterization of high- and low-affinity pyridine N-oxygenases. J. Pharmacol. Exp. Ther. 259:470-477.
11. Kim, H., Putt, D., Reddy, S., Hollenberg, P. F. and Novak, R. F. 1993. Enhanced expression of rat hepatic CYP2B1/2B2 and 2E1 by pyridine: Differential induction kinetics and molecular basis of expression. J. Pharmacol. Exp. Ther. 267:927-936.
12. Lister, J. L. and Virgo, B. B. 1982. Aniline and hexobarbital hydroxylases from rat lung and kidney: Neither sex dependent nor inducible with phenobarbital. Can. J. Physiol. Pharmacol. 60:1247-1250.
13. Litterst, C. L., Mimnaugh, E. G. and Gram, T. E. 1977. Comparative alterations in extrahepatic drug metabolism by factors known to affect hepatic activity. Biochem. Pharmacol. 26:749755.
14. Miller, R. R., Newhook, R. and Poole, A. 1994. Styrene production, use, and human exposure. Crit. Rev. Toxicol. 24(51):S1-S10.
15. Miyano, K., Fujii, Y. and Toki, S. 1980. Stereoselective hydroxylation of hexobarbital enantiomers by rat liver microsomes. Drug Metab. Dispos. 8:104-110.
16. Morgan, D. L., Mahler, J. F., O'Connor, R. W., Price, H. C. and Adkins, B. 1993a. Styrene inhalation toxicity studies in mice. I. Hepatotoxicity in B6C3F1 mice. Fundam. Appl. Toxicol. 20:325-335.
17. Morgan, D. L., Mahler, J. F., Dill, J. A., Price, H. C., O'Connor, R. W. and Adkins, B. 1993b. Styrene inhalation toxicity studies in mice. III. Strain differences in susceptibility. Fundam. Appl. Toxicol. 21:326-333.
18. Nakajima, T., Wang, R. S., Elovaara, E., Gonzalez, F. J., Gelboin, H. V., Vainio, H. and Aoyama, T. 1994a. CYP2C11 and CYP2B1 are major cytochrome P450 forms involved in styrene oxidation in liver and lung microsomes from untreated rats, respectively. Biochem. Pharmacol. 48:637-642.
19. Nakajima, T., Elovaara, E., Gonzalez, F. J., Gelboin, H. V., Raunio, H., Pelkonen, O., Vainio, H. and Aoyama, T. 1994b. Styrene metabolism by cDNA-expressed human hepatic and pulmonary cytochromes P450. Chem. Res. Toxicol. 7:891-896.
20. Nhamburo, P. T., Kimura, S., McBride, O. W., Kozak, C. A., Gelboin, H. V. and Gonzalez, F. J. 1990. The human CYP2F gene subfamily: Identification of a cDNA encoding a new cytochrome P450, cDNA-directed expression and chromosome mapping. Biochemistry 29:5491-5499.
21. Ono, S., Hatanaka, T., Hotta, H., Satoh, T., Gonzalez, F. J. and Tsutsui, M. 1996. Specificity of substrate and inhibitor probes for cytochrome P450s: Evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica 26:681-693.
22. Paolini, M., Mesirca, R., Pozzetti, L., Sapone, A. and Canteili-Forti, G. 1995. Induction of CYP2B1 mediated pentoxyresorufin O-dealkylase activity in different species, sex and tissue by prototype 2B1-inducers. Chem. Biol. Interact. 95:127-139.
23. Watabe, T., Ozawa, N. and Yoshikawa, K. 1981. Stereochemistry in the oxidative metabolism of styrene by hepatic microsomes. Biochem. Pharmacol. 30:1695-1698.
24. Watabe, T., Ozawa, N. and Hiratsuka, A. 1983. Studies on metabolism and toxicity of styrene-VI. Regioselectivity in glutathione 5-conjugation and hydrolysis of racemic, R- and 5-phenyl-oxiranes in rat liver. Biochem. Pharmacol. 32:777-785.